Inicio › Enfermedad de obstrucción pulmonar crónica › Florida › Miami
Ensayos clínicos de Enfermedad de obstrucción pulmonar crónica en Miami, FL
20 estudios para Enfermedad de obstrucción pulmonar crónica buscan participantes en centros de Miami y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-2)
ReclutandoFase 3
- GSK Investigational Site, Miami
A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis
ReclutandoFase 2
- Copd01 50011, Miami
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
ReclutandoFase 2
- Millennium Medical Research - Miami, Miami
Rademikibart IV for Acute Asthma and COPD Exacerbation
ReclutandoFase 2
- Pharmax Research of South Florida, Inc., Miami
A Study to Investigate the Efficacy and Safety of Zelicapavir Compared With Placebo in Adults With RSV Who Are at High Risk for Severe Disease
ReclutandoFase 2/3
- Continental Clinical Research, LLC, Miami
To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
ReclutandoFase 2
- Suncoast Research Group, LLC Miami - Little Havana dba Flourish Research, Miami
A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
ReclutandoFase 3
- GC2501 Study Site 105, Miami
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
ReclutandoFase 2
- Research Site, Miami
- Research Site, Miami
- Research Site, Miami
- y 2 más
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
ReclutandoFase 3
- Elite Clinical Research - Miami- Site Number : 8400167, Miami
- DL Research Solutions- Site Number : 8400140, Miami
- Phoenix Medical Research - Miami - 24th Street- Site Number : 8400027, Miami
- y 3 más
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
ReclutandoFase 2/3
- Reed Medical Research, Miami
A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
ReclutandoFase 4
- University of Miami Dermatology Clinical Trials Unit- Site Number : 8400015, Miami
- Finlay Medical Research- Site Number : 8400010, Miami
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
ReclutandoFase 3
- University of Miami Dermatology Clinical Trials Unit- Site Number : 8400078, Miami
- MCR Research- Site Number : 8400004, Miami
- Nuren Medical & Research Center- Site Number : 8400030, Miami
- y 2 más
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
ReclutandoFase 3
- Research Site, Miami
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
ReclutandoFase 3
- GSK Investigational Site, Miami
- GSK Investigational Site, Miami
- GSK Investigational Site, Miami
- y 4 más
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation
ReclutandoFase 3
- GSK Investigational Site, Miami
- GSK Investigational Site, Miami
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
ReclutandoFase 3
- Research Site, Miami
- Research Site, Miami
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
ReclutandoFase 3
- Research Site, Miami
- Research Site, Miami
- Research Site, Miami
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
ReclutandoFase 3
- GSK Investigational Site, Miami
- GSK Investigational Site, Miami
- GSK Investigational Site, Miami
Physiologic Effects of Nasal High Flow on Exercise Tolerance in COPD
Reclutando
- University of Miami, Miami
myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
Reclutando
- Reliable Research, Inc., Miami
- NewGen Health Group, Miami
Más información sobre Enfermedad de obstrucción pulmonar crónica en MedlinePlus
Ensayos de Enfermedad de obstrucción pulmonar crónica en otras ciudades
- Philadelphia, PA26 estudios
- Houston, TX18 estudios
- Birmingham, AL17 estudios
- Baltimore, MD16 estudios
- Boston, MA15 estudios
- Orlando, FL15 estudios
- Chicago, IL15 estudios
- Dallas, TX13 estudios
- New York City, NY12 estudios
- Pittsburgh, PA11 estudios
- Winston-Salem, NC11 estudios
- Hialeah, FL10 estudios
Otros estudios en Miami
- Cáncer de seno42 estudios
- Cáncer (todos los tipos)36 estudios
- Cáncer de pulmón de células no pequeñas35 estudios
- Cáncer de próstata30 estudios
- Obesidad28 estudios
- Cáncer de ovario24 estudios
- Leucemia mielógena aguda24 estudios
- Sobrepeso23 estudios
- Cáncer metastásico22 estudios
- Mieloma múltiple22 estudios
- Cáncer de pulmón22 estudios
- Enfermedad de Alzheimer21 estudios
De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.